Alvircept sudotox

• UNSPSC Description:

  Alvircept sudotox is a recombinant CD4 derived from Pneumonas aeruginosa exotoxin A. Alvircept sudotox can be used in the research of HIV infections[1].

• Target Antigen:

  HIV

• Type:

  Inhibitory Antibodies

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/alvircept-sudotox.html

• Solubility:

  10 mM in DMSO

• Smiles:

  [Alvircept sudotox]

• References & Citations:

  [1]Prendergast, et al. Anti-mineralocorticoid therapy of infection. Patent. WO2007049265.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  137487-62-8